We conducted a randomized , double-blind , placebo-controlled trial of Polyphenon E ( decaffeinated and enriched green tea catechin extract ) in women with persistent human papillomavirus ( HPV ) infection and low-grade cervical intraepithelial neoplasia ( CIN1 ) to evaluate the potential of Polyphenon E for cervical cancer prevention .